Ipsen raises 2026 sales growth outlook to 23% after Q3 sales jump 28%
FROM THE WIRE · SEEKINGALPHA.COM
* Ipsen S.A. press release [https://seekingalpha.com/pr/20695612-ipsen-delivers-outstanding-sales-growth-in-the-first-nine-months-of-2026-and-further-upgrades] (IPSEY [https://seekingalpha.com/symbol/IPSEY]): Q3 Sales of €1.17B, up 28.3% as reported and 26.7% at constant…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishUpgraded guidance from a mid-sized pharma group, with margins also raised.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 sales were €1.17B, up 28.3% as reported.
- 02FY 2026 sales growth guidance was raised to around 23% at CER.
- 03Core operating margin guidance was increased to around 39% of sales.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Ipsen S.A.43.00 USDMarket closedtoday +5.05%Positive Ipsen S.A.113.13 USDMarket closedtoday 0.00%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets